Cargando…
Combination of paeoniflorin and liquiritin alleviates neuropathic pain by lipid metabolism and calcium signaling coordination
Neuropathic pain (NP) affects 7%–10% of the general population and is still hard to cure. Here, we validated the therapeutic effect and demonstrated the mechanism of paeoniflorin and liquiritin combination (PL) on NP from the perspective of integrated lipidomics and transcriptomics for the first tim...
Autores principales: | Chen, Yan-Yan, Feng, Li-Mei, Xu, Ding-Qiao, Yue, Shi-Jun, Fu, Rui-Jia, Zhang, Mei-Mei, Tang, Yu-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489943/ https://www.ncbi.nlm.nih.gov/pubmed/36160378 http://dx.doi.org/10.3389/fphar.2022.944386 |
Ejemplares similares
-
Biomolecular network-based synergistic drug combination discovery: a combination of paeoniflorin and liquiritin alleviates neuropathic pain by inhibiting neuroinflammation via suppressing the chemokine signaling pathway
por: Guo, Qiuyan, et al.
Publicado: (2020) -
Liquiritin Alleviates Pain Through Inhibiting CXCL1/CXCR2 Signaling Pathway in Bone Cancer Pain Rat
por: Ni, Huadong, et al.
Publicado: (2020) -
Paeoniflorin alleviates liver injury in hypercholesterolemic rats through the ROCK/AMPK pathway
por: Liu, Tong, et al.
Publicado: (2022) -
Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022) -
The Protective Effect of Liquiritin in Hypoxia/Reoxygenation-Induced Disruption on Blood Brain Barrier
por: Li, Mengting, et al.
Publicado: (2021)